Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

BCC UKB basal cell carcinoma in the UK Biobank, SCC UKB squamous cell carcinoma in the UK Biobank, CM cutaneous melanoma, KC QSkin keratinocyte cancer in the QSkin cohort, KC eMERGE keratinocyte cancer in the eMERGE cohort, Hypothyr hypothyroidism, T1Dtype 1 diabetes, EA education attainment, VitD vitamin D, AAT aspartate aminotransferase, CRP C-reactive protein, GGT gamma-glutamyl transferase and Corr correlation.

Source: Genetic correlation. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

In general, at baseline, information on relevant variants, including age and sex, were recorded, and participants were also asked whether they had been diagnosed with any cancer, including KC (yes/no), by a health professional.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A multi-phenotype analysis reveals 19 susceptibility loci for basal cell carcinoma and 15 for squamous cell carcinoma

Study design awaiting verification · Nature Communications · 2022

Original publication title

A multi-phenotype analysis reveals 19 susceptibility loci for basal cell carcinoma and 15 for squamous cell carcinoma

Mathias Seviiri; Matthew H. Law; Jue-Sheng Ong; Puya Gharahkhani; Pierre Fontanillas; The 23andMe Research TeamAslibekyanStella4AutonAdam4BabalolaElizabeth4BellRobert K.4BielenbergJessica4BrycKatarzyna4BullisEmily4CokerDaniella4PartidaGabriel Cuellar4DhamijaDevika4DasSayantan4ElsonSarah L.4FilshteinTeresa4Fletez-BrantKipper4FreymanWill4GandhiPooja M.4HeilbronKarl4HicksBarry4HindsDavid A.4JewettEthan M.4JiangYunxuan4KukarKatelyn4LinKeng-Han4LoweMaya4McCreightJey4McIntyreMatthew H.4MichelettiSteven J.4MorenoMeghan E.4MountainJoanna L.4NandakumarPriyanka4NoblinElizabeth S.4O’ConnellJared4PetrakovitzAaron A.4PoznikG. David4SchumacherMorgan4ShastriAnjali J.4SheltonJanie F.4ShiJingchunzi4ShringarpureSuyash4TranVinh4TungJoyce Y.4WangXin4WangWei4WeldonCatherine H.4WiltonPeter4HernandezAlejandro4WongCorinna4TchakoutéChristophe Toukam4; Catherine M. Olsen; David C. Whiteman; Stuart MacGregor

© The Author(s) 2022

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Basal cell carcinoma and squamous cell carcinoma are the most common skin cancers, and have genetic overlap with melanoma, pigmentation traits, autoimmune diseases, and blood biochemistry biomarkers. In this multi-trait genetic analysis of over 300,000 participants from Europe, Australia and the United States, we reveal 78 risk loci for basal cell carcinoma (19 previously unknown and replicated) and 69 for squamous cell carcinoma (15 previously unknown and replicated). The previously unknown risk loci are implicated in cancer development and progression (e.g. CDKL1), pigmentation (e.g. TPCN2), cardiometabolic (e.g. FADS2), and immune-regulatory pathways for innate immunity (e.g. IFIH1), and HIV-1 viral load modulation (e.g. CCR5).

We also report an optimised polygenic risk score for effective risk stratification for keratinocyte cancer in the Canadian Longitudinal Study of Aging (794 cases and 18139 controls), which could facilitate skin cancer surveillance e.g. in high risk subpopulations such as transplantees.

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common skin cancers and have genetic overlap. Here, the authors use a multi-trait genetic and phenotypic analysis to reveal susceptibility loci for BCC and SCC, and report an optimised polygenic risk score for risk stratification.

Authors’ abstract

Basal cell carcinoma and squamous cell carcinoma are the most common skin cancers, and have genetic overlap with melanoma, pigmentation traits, autoimmune diseases, and blood biochemistry biomarkers. In this multi-trait genetic analysis of over 300,000 participants from Europe, Australia and the United States, we reveal 78 risk loci for basal cell carcinoma (19 previously unknown and replicated) and 69 for squamous cell carcinoma (15 previously unknown and replicated). The previously unknown risk loci are implicated in cancer development and progression (e.g. CDKL1), pigmentation (e.g. TPCN2), cardiometabolic (e.g. FADS2), and immune-regulatory pathways for innate immunity (e.g. IFIH1), and HIV-1 viral load modulation (e.g. CCR5).

We also report an optimised polygenic risk score for effective risk stratification for keratinocyte cancer in the Canadian Longitudinal Study of Aging (794 cases and 18139 controls), which could facilitate skin cancer surveillance e.g. in high risk subpopulations such as transplantees.

Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common skin cancers and have genetic overlap. Here, the authors use a multi-trait genetic and phenotypic analysis to reveal susceptibility loci for BCC and SCC, and report an optimised polygenic risk score for risk stratification.

Publication and source details

Original title: A multi-phenotype analysis reveals 19 susceptibility loci for basal cell carcinoma and 15 for squamous cell carcinoma

Mathias Seviiri; Matthew H. Law; Jue-Sheng Ong; Puya Gharahkhani; Pierre Fontanillas; The 23andMe Research TeamAslibekyanStella4AutonAdam4BabalolaElizabeth4BellRobert K.4BielenbergJessica4BrycKatarzyna4BullisEmily4CokerDaniella4PartidaGabriel Cuellar4DhamijaDevika4DasSayantan4ElsonSarah L.4FilshteinTeresa4Fletez-BrantKipper4FreymanWill4GandhiPooja M.4HeilbronKarl4HicksBarry4HindsDavid A.4JewettEthan M.4JiangYunxuan4KukarKatelyn4LinKeng-Han4LoweMaya4McCreightJey4McIntyreMatthew H.4MichelettiSteven J.4MorenoMeghan E.4MountainJoanna L.4NandakumarPriyanka4NoblinElizabeth S.4O’ConnellJared4PetrakovitzAaron A.4PoznikG. David4SchumacherMorgan4ShastriAnjali J.4SheltonJanie F.4ShiJingchunzi4ShringarpureSuyash4TranVinh4TungJoyce Y.4WangXin4WangWei4WeldonCatherine H.4WiltonPeter4HernandezAlejandro4WongCorinna4TchakoutéChristophe Toukam4; Catherine M. Olsen; David C. Whiteman; Stuart MacGregor

Nature Communications · 2022

© The Author(s) 2022https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.https://doi.org/10.13039/501100000925Department of Health | National Health and Medical Research Council (NHMRC)APP1073898APP1063061APP1073898APP1063061Whiteman David C. MacGregor Stuart

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T21:36:33.406068+00:00

DOI: 10.1038/s41467-022-35345-8 · PMC9741635